Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
This document reports the results of a Phase 2 clinical trial evaluating efavirenz as second-line therapy for metastatic pancreatic cancer. …
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]
Phase 2 trial evaluating high-dose vitamin C (ascorbate) for pancreatic cancer has completed (PACMAN 2.1).
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
A Phase 1/2 study of TC-510 from TCR2 Therapeutics in mesothelin-expressing cancers is active but not recruiting, spanning multiple indicati…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) [NA]
ClinicalTrials.gov update reports that the PREV-Ex trial evaluating blood flow restriction exercise in patients with pancreatic cancer, bili…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Enhanced Assistance During Radiotherapy for Unmet Essential Needs [NA]
A completed clinical trial evaluated enhanced assistance during radiotherapy to address unmet essential needs across multiple cancer types.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update reporting completed Phase 1/2 evaluation of combining siltuximab and spartalizumab in metastatic pancreatic cancer; re…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors [Phase 1]
A Phase I trial evaluating intratumoral injection of GC001, an oncolytic vaccinia virus, in patients with advanced solid tumors is currently…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) [Phase 1, Phase 2]
Phase 1/2 trial results for GLIMMER-01, a bi-sialidase fusion protein from Palleon, tested across multiple solid tumors with results posted …
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
A post-marketing surveillance trial of olaparib (Lynparza) conducted by AstraZeneca has completed, reporting safety monitoring results acros…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors [Phase 1]
A Phase 1 trial evaluating tovorafenib (DAY101) alone or with pimasertib for melanoma and other solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 64Cu-LNTH-1363S in patients with metastatic sarcoma and GI tract cancers (esophageal, gastric, pancrea…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 [NA]
Phase 2 trial investigating an end-of-life conversation game to engage cancer patients in advance care planning; the study is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers [EARLY_Phase 1]
An early-phase clinical trial update for Ga-68 MTP220 PET assessing biodistribution and potential efficacy in head and neck cancer and pancr…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
The DELFI-L101 study from Delfi Diagnostics, which evaluates DNA fragment analysis for early interception of cancer, has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating niraparib in combination with dostarlimab for germline or somatic BRCA1/2 and PALB2-mutated metastatic pancreatic c…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating FOLFIRINOX with digoxin in patients with resectable pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating nivolumab, cabiralizumab, and gemcitabine in patients with stage IV pancreatic cancer has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT [NA]
Completed clinical trial comparing 18F-AlF-FAPI PET/CT with 18F-FDG PET/CT in patients with gastric cancer, pancreatic cancer, and hepatocel…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics reports long-term follow-up data from subjects treated with autologous T cells engineered with a Sleeping Beauty system…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection [Phase 3]
Phase 3 trial evaluating the use of intraoperative epidurals during pancreatic resection has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study [Phase 2]
Phase 2 study (VERTPAC-02) evaluating ultrasound-guided verteporfin photodynamic therapy for unresectable solid pancreatic tumors or advance…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer [Phase 2]
Phase 2 trial update for INCMGA00012 in previously treated unresectable or metastatic adenosquamous pancreatic or ampullary cancer (NCT04116…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Multivisceral Oncological Resections Involving the Pancreas - An International Multicenter Study
This document reports the completion of an international multicenter trial evaluating multivisceral oncological resections involving the pan…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating hydroxychloroquine in combination with gemcitabine and Abraxane in pancreatic cancer has completed.